IBRANCE125mg Pfizer treats patients with breast cancer (1 blister x 7 tablets)
Dosage form Box of 1 blister x 7 tablets
Specifications Palbociclib
Ingredient
| Composition information | Content |
| Palbociclib | 125mg |
Uses
indications
Ibrance125mg drug is indicated in the following cases:
Treatment of metastatic or advanced breast cancer, positive with hormone receptors (HR), receptor of epidermal growth factor (Her2) negative:
Pharmacological
No data.
pharmacokinetics
No data.
Before taking IBRANCE125mg Pfizer treats patients with breast cancer (1 blister x 7 tablets)
How to use
Take oral use.
Dosage
Specific dose depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose? What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that double dose should not be used.
Side Effects
Notify the physician the unwanted effects when using the drug.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Ibran125mg drug contraindicated in the following cases:
Caution when using
No data.
The effect of the drug on driving and operating machinery
No data.
Use drugs for women during pregnancy and lactation
No data.
Drug interaction
drug interactions can affect the activity of the drug or cause side effects.
Patients should notify the doctor or pharmacist a list of the drugs and functional foods you are using. Do not use or increase or decrease the dose of the drug without the guidance of a doctor.
Storage
Leave a cool place, avoid light, temperature below 30⁰C.
To be out of reach of children, read the user manual carefully before use.
Other drugs
- ANDROCUR 50MG TABLETS
- DYTIDE CAPSULES
- FUSIDIC ACID / BETAMETHASONE 20 MG / G + 1 MG / G CREAM
- Helixate NexGen
- MERIOFERT 150 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
- MIACALCIC 200 I.U. NASAL SPRAY SOLUTION
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions